Gujarat FDCA approves licences of 189 hand sanitisers to meet growing demand amidst COVID-19 pandemic

The Gujarat FDCA has approved product licences of 189 hand sanitisers to tide over its growing demand due to the pandemic. The product licenses are mostly from small and medium Indian manufacturers which are complying with the provisions of cosmetic rules.

Adequate supply of sanitisers and antiretroviral (ARV) drugs like chloroquine phosphate has been maintained in the wake of pandemic.

According to an official associated with the development, “A state level committee has also been formed to oversee the consistent supply of ARV drugs, masks and sanitisers.”

The committee is headed by Gujarat Food and Drug Control Administration (FDCA) Commissioner Dr HG Koshia with members from the state industry department and state pollution control board.

Dr Koshia informed that, “This has to be followed religiously as the Central Government has notified Essential Commodities (EC) Order, 2020 to regulate the production, quality, distribution, logistics of masks (2ply and 3ply surgical masks, N95 masks) and hand sanitizers for COVID-19 management. We have made the provision of approving licenses for sanitisers production and distribution under the emergency use authorization for consistent supply.”
The EC order notification shall remain in force for a period up to June 30, 2020 from the date of its publication in the official gazette.

  • Related Posts

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

    An Impacted Denture accidently  had lodged inside it New Delhi: In a remarkable medical achievement, doctors at Sir Ganga Ram Hospital successfully removed an impacted dental plate that had accidentally…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

    Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS